EQR vs PRME · P/E 26, $26.37B cap vs rev $4.6M
Equity Residential (EQR) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Equity Residential (EQR) is a reit - residential company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
EQR does not have a complete income-statement cache yet.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
EQR currently screens at market cap $26.37B and trailing P/E 25.7. PRME currently screens at market cap $570.8M.
Not investment advice. Open the EQR and PRME stock pages for the full models.
Not investment advice.